Antonio J. Gracias Tesla, Inc. (TSLA) insider trading activity

Antonio J. Gracias is Director of Tesla, Inc.. Currently has a direct ownership of 2,545 shares of TSLA, which is worth approximately $1.1 Million. The most recent transaction as insider was on Dec 21, 2018, when has been sold 7,200 shares (Common Stock) at a price of $30.08 per share, resulting in proceeds of $216,576. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.55K

0% 3M change

0% 12M change

Total Value Held $1.1 Million

Antonio J. Gracias Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 21 2018	BUY Exercise of conversion of derivative security	$216,576 $30.08 p/Share	7,200 Added 23.73%	23,142 Common Stock
Dec 20 2018	SELL Open market or private sale	$2,690,002 $320.62 p/Share	8,390 Reduced 34.48%	15,942 Common Stock
Dec 20 2018	BUY Exercise of conversion of derivative security	$216,576 $30.08 p/Share	7,200 Added 22.83%	24,332 Common Stock
May 07 2018	BUY Exercise of conversion of derivative security	$473,814 $28.43 p/Share	16,666 Added 49.31%	17,132 Common Stock
May 25 2017	BUY Other acquisition or disposition	-	466 Added 50.0%	466 Common Stock
Feb 24 2017	SELL Open market or private sale	$1,392,245 $254.71 p/Share	5,466 Reduced 100.0%	0 Common Stock
Feb 24 2017	BUY Exercise of conversion of derivative security	$54,441 $9.96 p/Share	5,466 Added 50.0%	5,466 Common Stock
Feb 06 2017	SELL Open market or private sale	$1,426,992 $254.82 p/Share	5,600 Reduced 100.0%	0 Common Stock
Feb 06 2017	BUY Exercise of conversion of derivative security	$55,776 $9.96 p/Share	5,600 Added 50.0%	5,600 Common Stock
Jan 25 2017	SELL Open market or private sale	$1,427,272 $254.87 p/Share	5,600 Reduced 100.0%	0 Common Stock
Jan 25 2017	BUY Exercise of conversion of derivative security	$55,776 $9.96 p/Share	5,600 Added 50.0%	5,600 Common Stock
Nov 07 2013	BUY Other acquisition or disposition	-	2,231 Added 2.39%	90,993 Common Stock

Also insider at

HRMY

Harmony Biosciences Holdings, Inc. Healthcare

AJG